Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
Cancer Medicine · 2024
DOI: 10.1002/cam4.6867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Frantisek Zitricky und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Pharyngeal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020, grant no. 856620 (Chaperon).
Abstract (Originalsprache)
Background
Cancers of the head and neck (HN) are heterogeneous tumors with incidence rates varying globally. In Northern Europe oral and oropharyngeal cancers are the most common individual types. Survival for HN varies by individual tumor type but for most of them survival trends are not well known over extended periods of time.
Methods
Data for a retrospective survival study were obtained for Danish, Finnish, Norwegian, and Swedish patients from the NORDCAN database from 1971 to 2020. Relative 1‐ and 5‐year survival rates and 5/1‐year conditional survival for years 2–5 were calculated.
Results
Both 1‐ and 5‐year survival improved for all HN cancers but only marginally for laryngeal cancer. For the other cancers a 50‐year increase in 5‐year survival was about 30% units for nasopharyngeal and oropharyngeal cancers, 20% units for oral cancer and somewhat less for hypopharyngeal cancer.
Conclusions
5‐year survival reached about 65% for all HN cancers, except for hypopharyngeal cancer (30%). Human papilloma virus infection is becoming a dominant risk factor for the rapidly increasing oropharyngeal cancer, the prevention of which needs to emphasize oral sex as a route of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic.
- Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
- Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
ORCID-Profile: Frantisek Zitricky, Akseli Hemminki, Kari Hemminki
Förderung
- European Union's Horizon 2020, grant no. 856620 (Chaperon)
Zitieren
APA
Zitricky, F., Koskinen, A. I., Hemminki, O., Försti, A., Hemminki, A., & Hemminki, K. (2024). Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer Medicine. https://doi.org/10.1002/cam4.6867
Vancouver
Zitricky F, Koskinen AI, Hemminki O, Försti A, Hemminki A, Hemminki K. Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer Medicine. 2024. doi:10.1002/cam4.6867
BibTeX
@article{Zitricky2024,
author = {Zitricky, Frantisek and Koskinen, Anni I and Hemminki, Otto and Försti, Asta and Hemminki, Akseli and Hemminki, Kari},
title = {Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6867}
}
EUVIMED